StreetInsider.com News Articles

cbdMD agrees to acquire Twinlab brands in court-pending deal

Wed, 02 Sep 2026 07:36:34 -0400

cbdMD, Inc. (NYSE American: YCBD) has entered into a definitive asset purchase agreement to acquire operating assets and brands from Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea, according to a press release from the Charlotte, N.C.-based company.

The acquisition is being conducted through an assignment for the benefit of creditors proceeding and remains subject to court approval and customary closing conditions.

Based on unaudited financial information, the combined trailing twelve months of revenue ending June 2026 totals approximately $30 million, which the company says would represent an increase of approximately 40% relative to cbdMD's standalone revenue for the same period. The

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

Wed, 02 Sep 2026 07:36:00 -0400

Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million.

CHARLOTTE, N.C., Sept. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company, today announced

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

Wed, 02 Sep 2026 07:36:00 -0400

Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million.

CHARLOTTE, N.C., Sept. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company, today announced

Maxim Group Downgrades cbdMD Inc. (YCBD) to Hold

Mon, 17 Aug 2026 08:12:37 -0400

Maxim Group analyst Anthony Vendetti downgraded cbdMD Inc. (NYSE: YCBD) from Buy to Hold.

For an analyst ratings summary and ratings history on cbdMD Inc. click here. For more ratings news on cbdMD Inc. click here.

Shares of cbdMD Inc. closed at $0.50 yesterday.

cbdMD, Inc. (YCBD) Misses Q2 EPS by 7c

Thu, 13 Aug 2026 16:13:29 -0400

cbdMD, Inc. (NYSE: YCBD) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.55 million versus the consensus estimate of $5.39 million.

For earnings history and earnings-related data on cbdMD, Inc. (YCBD) click here.

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

Thu, 13 Aug 2026 16:10:00 -0400

Accelerating Oasis Beverage Momentum, a Full Quarter of Bluebird Botanical Contribution, and Advancing Federal Hemp Legislation Strengthen the Company's Positioning for Competing under Pending Federal Regulations

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

Thu, 13 Aug 2026 16:10:00 -0400

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

Thu, 13 Aug 2026 16:10:00 -0400

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

Thu, 13 Aug 2026 16:10:00 -0400

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

Mon, 10 Aug 2026 15:07:00 -0400

CHARLOTTE, N.C., Aug. 10, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 13, 2026, to discuss the company's June 30, 2026 third quarter financial results and business progress.

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

Mon, 10 Aug 2026 15:07:00 -0400

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

Mon, 10 Aug 2026 15:07:00 -0400

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

Mon, 10 Aug 2026 15:07:00 -0400

Senate bill would delay hemp restrictions, cbdMD says portfolio protected

Mon, 03 Aug 2026 11:31:43 -0400

cbdMD, Inc. (NYSE American: YCBD) said it welcomes proposed Senate spending legislation that would delay pending federal restrictions on most hemp products from November 12 to December 11, 2026.

Senate Appropriations Committee leaders released the text of a continuing resolution on August 2 to fund federal agencies through December 11. The bill includes provisions that would temporarily preserve the current federal framework for naturally derived hemp products. Certain synthetic cannabinoids "not capable of being naturally produced by a Cannabis sativa L. plant" would still face restrictions on the original November 12 timeline under a carve-out in the bill.

cbdMD said its assessment

cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products